ETCTN P10500: PHASE 1/EXPANSION STUDY OF TAZEMETOSTAT PLUS BELINOSTAT FOR THE TREATMENT OF RELAPSED OR REFRACTORY LYMPHOMA

Amengual, J. E., Shyr, Y., Durecki, D., Beumer, J. H., Mansukhani, M. M., Williams, M., Kelleher, N., Cherng, H., Pro, B., Schwartz, G. K., LoRusso, P., & Piekarz, R. (2023). ETCTN P10500: PHASE 1/EXPANSION STUDY OF TAZEMETOSTAT PLUS BELINOSTAT FOR THE TREATMENT OF RELAPSED OR REFRACTORY LYMPHOMA. Hematological Oncology, 41(S2), 833–834. Portico. https://doi.org/10.1002/hon.3166_ot14
Authors:
Jennifer E. Amengual
Yu Shyr
Diane E. Durecki
Jan H. Beumer
Mahesh Mansukhani
M. Williams
Neil L. Kelleher
Hua‐Jay J. Cherng
Barbara Pro
Gary K. Schwartz
Patricia LoRusso
Richard Piekarz
Affiliated Authors:
Jennifer E. Amengual
Mahesh Mansukhani
Hua‐Jay J. Cherng
Barbara Pro
Gary K. Schwartz
Columbia Affiliation:
Subjects:
Role of Histone Deacetylases in Cellular Regulation (OpenAlex Topic)
Protein Arginine Methylation in Mammals (OpenAlex Topic)
Click Chemistry in Chemical Biology and Drug Development (OpenAlex Topic)
elink
Publication Type:
Article
Unique ID:
10.1002/hon.3166_ot14
DOI:
10.1002/hon.3166_ot14
Journal:
Hematological Oncology
Publication Date:
Data Source:
OpenAlex
Source Link:
View OpenAlex Record

Record Created: